Literature DB >> 21279723

Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Jian Wang1, Xi Wang, Hong Yang, Dong Wu, Li Wang, Jiaming Qian.   

Abstract

To evaluate the association of the IBD5 locus to the predisposition of inflammatory bowel diseases (IBDs), a series of meta-analyses between five IBD5 variants (OCTN1 C1672T, OCTN2 G-207C, OCTN1/2 TC haplotype, IGR2096a_1, IGR2198a_1 and IGR2230a_1) and Crohn's disease (CD) and ulcerative colitis (UC) were performed, which included a total of 26 studies. Overall, five IBD5 variants in a per-allele model of inheritance were significantly associated with elevated CD risk (for OCTN1: OR = 1.23, 95% CI = 1.16-1.30, P < 0.001; for OCTN2: OR = 1.20, 95% CI = 1.11-1.30, P < 0.001; for IGR2096a_1: OR = 1.36, 95% CI = 1.24-1.46, P < 0.001; for IGR2198a_1: OR = 1.34, 95% CI = 1.24-1.46, P < 0.001; for IGR2230a_1: OR = 1.35, 95% CI = 1.23-1.48, P < 0.001) and OCTN1/2 TC haplotype (OR = 1.32, 95% CI = 1.22-1.43, P < 0.001). In the subgroup analysis, the statistically significant associations were also observed in adult- and pediatric-onset CD and in Caucasians for five IBD5 variants and the OCTN1/2 TC haplotype. A statistically significant increase in the risk of UC was detected in a recessive model of inheritances for OCTN1 (OR = 1.23, 95% CI = 1.08-1.40, P < 0.001), OCTN2 (OR = 1.18, 95% CI = 1.05-1.33, P = 0.006), IGR2096a_1 (OR = 1.37, 95% CI = 1.15-1.62, P < 0.001) and IGR2198a_1 (OR = 1.35, 95% CI = 1.10-1.66, P = 0.004); the increased risks of UC were maintained in the adult and Caucasian subgroups, but not the pediatric subgroup. In summary, our results suggested that the IBD5 locus contributes to the susceptibility of CD in a per-allele manner in adults, children and Caucasians, and the locus contributes to the susceptibility of UC in a recessive manner in adult and Caucasian populations.

Entities:  

Mesh:

Year:  2011        PMID: 21279723     DOI: 10.1007/s00439-011-0952-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  72 in total

Review 1.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

Review 2.  The genetics of inflammatory bowel disease.

Authors:  Judy H Cho; Casey T Weaver
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

3.  Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.

Authors:  Toshihiko Okazaki; Ming-Hsi Wang; Patricia Rawsthorne; Michael Sargent; Lisa Wu Datta; Yin Yao Shugart; Charles N Bernstein; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

4.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.

Authors:  H-P Török; J Glas; L Tonenchi; P Lohse; B Müller-Myhsok; O Limbersky; C Neugebauer; F Schnitzler; J Seiderer; C Tillack; S Brand; G Brünnler; P Jagiello; J T Epplen; T Griga; W Klein; U Schiemann; M Folwaczny; T Ochsenkühn; C Folwaczny
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

5.  Contribution of IBD5 locus to clinical features of IBD patients.

Authors:  Anna Latiano; O Palmieri; Rossella M Valvano; Renata D'Incà; Maurizio Vecchi; Angelo Ferraris; Giacomo C Sturniolo; Luisa Spina; Giovanni Lombardi; Bruno Dallapiccola; Angelo Andriulli; Marcella Devoto; Vito Annese
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

6.  Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).

Authors:  Harunobu Tahara; Sook Wah Yee; Thomas J Urban; Stephanie Hesselson; Richard A Castro; Michiko Kawamoto; Doug Stryke; Susan J Johns; Thomas E Ferrin; Pui-Yan Kwok; Kathleen M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

7.  Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort.

Authors:  Euphemia Leung; Jiwon Hong; Alan G Fraser; Tony R Merriman; Prakash Vishnu; Geoffrey W Krissansen
Journal:  Immunol Cell Biol       Date:  2006-04       Impact factor: 5.126

8.  Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.

Authors:  R K Russell; H E Drummond; E R Nimmo; N H Anderson; C L Noble; D C Wilson; P M Gillett; P McGrogan; K Hassan; L T Weaver; W M Bisset; G Mahdi; J Satsangi
Journal:  Gut       Date:  2006-02-09       Impact factor: 23.059

9.  Contribution of the IBD5 locus to Crohn's disease in the Swedish population.

Authors:  Leif Törkvist; Colin L Noble; Mikael Lördal; Urban Sjöqvist; Ulrik Lindforss; Elaine R Nimmo; Robert Löfberg; Richard K Russell; Jack Satsangi
Journal:  Scand J Gastroenterol       Date:  2007-02       Impact factor: 2.423

10.  Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients.

Authors:  Pawel Gaj; Andrzej Habior; Michal Mikula; Jerzy Ostrowski
Journal:  BMC Med Genet       Date:  2008-08-21       Impact factor: 2.103

View more
  5 in total

1.  Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.

Authors:  Ming-Hsi Wang; Toshihiko Okazaki; Subra Kugathasan; Judy H Cho; Kim L Isaacs; James D Lewis; Duane T Smoot; John F Valentine; Howard A Kader; Jean G Ford; Mary L Harris; Maria Oliva-Hemker; Carmen Cuffari; Michael S Torbenson; Richard H Duerr; Mark S Silverberg; John D Rioux; Kent D Taylor; Geoffrey C Nguyen; Yuqiong Wu; Lisa W Datta; Stanley Hooker; Themistocles Dassopoulos; Rick A Kittles; Linda W H Kao; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2012-03-12       Impact factor: 5.325

Review 2.  Human Intestinal Barrier Function in Health and Disease.

Authors:  Julia König; Jerry Wells; Patrice D Cani; Clara L García-Ródenas; Tom MacDonald; Annick Mercenier; Jacqueline Whyte; Freddy Troost; Robert-Jan Brummer
Journal:  Clin Transl Gastroenterol       Date:  2016-10-20       Impact factor: 4.488

3.  Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.

Authors:  Seda Ekizoglu; Didem Seven; Turgut Ulutin; Jalal Guliyev; Nur Buyru
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

4.  Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response.

Authors:  Srinivas Sonne; Prem S Shekhawat; Dietrich Matern; Vadivel Ganapathy; Leszek Ignatowicz
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

5.  Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease.

Authors:  Xue Li; Peige Song; Maria Timofeeva; Xiangrui Meng; Igor Rudan; Julian Little; Jack Satsangi; Harry Campbell; Evropi Theodoratou
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.